Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Chevron
CVX
|
+$718M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$469M |
| 4 |
Shopify
SHOP
|
+$439M |
| 5 |
Meta Platforms (Facebook)
META
|
+$401M |
Top Sells
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 3 |
Tesla
TSLA
|
+$543M |
| 4 |
Verizon
VZ
|
+$535M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.81% |
| 3 | Consumer Staples | 11.14% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHRA
3701
DELISTED
Charah Solutions, Inc Common Stock
CHRA
| $173K | ﹤0.01% |
4,620
+180
| +4% | +$6.74K |
|
3702
DSS Inc
DSS
$11.3M
| $171K | ﹤0.01% |
26,190
-23,365
| -47% | -$153K |
|
3703
US Global Investors
GROW
$31.7M
| $171K | ﹤0.01% |
38,615
-43,000
| -53% | -$190K |
|
3704
Nautilus Biotechnolgy
NAUT
$89.3M
| $171K | ﹤0.01% |
63,600
+52,600
| +478% | +$141K |
|
|
SEI
3705
Solaris Energy Infrastructure, Inc.
SEI
$1.31B
| $171K | ﹤0.01% |
15,700
+4,200
| +37% | +$45.7K |
|
|
PTRS
3706
DELISTED
Partners Bancorp Common Stock
PTRS
| $171K | ﹤0.01% |
18,900
-13,400
| -41% | -$121K |
|
3707
Avalo Therapeutics
AVTX
$145M
| $170K | ﹤0.01% |
118
-9
| -7% | -$13K |
|
|
TKLF
3708
Yoshitsu Co
TKLF
$14.9M
| $170K | ﹤0.01% |
+10,080
| New | +$170K |
|
3709
urban-gro
UGRO
$7.67M
| $170K | ﹤0.01% |
35,200
-30,271
| -46% | -$146K |
|
3710
FlexShopper
FPAY
$17M
| $169K | ﹤0.01% |
187,655
-63,945
| -25% | -$57.6K |
|
|
SMTS
3711
DELISTED
Sierra Metals Inc. Common Stock
SMTS
| $169K | ﹤0.01% |
210,900
-299,877
| -59% | -$240K |
|
3712
Pro-Dex
PDEX
$116M
| $168K | ﹤0.01% |
+10,540
| New | +$168K |
|
3713
Predictive Oncology
POAI
$10.9M
| $166K | ﹤0.01% |
20,255
+19,500
| +2,583% | +$160K |
|
3714
Solid Power
SLDP
$645M
| $166K | ﹤0.01% |
30,800
+8,000
| +35% | +$43.1K |
|
|
SIOX
3715
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $166K | ﹤0.01% |
460,394
-106,759
| -19% | -$38.5K |
|
3716
Bloom Energy
BE
$14.7B
| $165K | ﹤0.01% |
10,000
+1,600
| +19% | +$26.4K |
|
3717
Inhibikase Therapeutics
IKT
$115M
| $165K | ﹤0.01% |
36,983
+5,571
| +18% | +$24.9K |
|
|
NCTY
3718
The9 Ltd
NCTY
$134M
| $165K | ﹤0.01% |
9,814
+7,976
| +434% | +$134K |
|
3719
Phio Pharmaceuticals
PHIO
$14.1M
| $165K | ﹤0.01% |
2,175
+1,791
| +466% | +$136K |
|
3720
Soluna Holdings
SLNH
$17.9M
| $165K | ﹤0.01% |
+1,620
| New | +$165K |
|
|
BIOC
3721
DELISTED
Biocept, Inc.
BIOC
| $165K | ﹤0.01% |
5,850
+1,970
| +51% | +$55.6K |
|
3722
Arts-Way Manufacturing Co
ARTW
$15.8M
| $164K | ﹤0.01% |
55,274
+16,900
| +44% | +$50.1K |
|
3723
Paranovus Entertainment Technology
PAVS
$57.2M
| $163K | ﹤0.01% |
38,919
+19,970
| +105% | +$83.6K |
|
|
FEDU
3724
Four Seasons Education Depositary Shares Rep 10 Ordinary Shares
FEDU
$32.4M
| $162K | ﹤0.01% |
14,947
+3,229
| +28% | +$35K |
|
|
DMTK
3725
DELISTED
DermTech, Inc. Common Stock
DMTK
| $162K | ﹤0.01% |
29,200
-7,300
| -20% | -$40.5K |
|